CD44v6 expression in non-anaplastic thyroid carcinoma: characterization of candidates for targeted therapy

Adam Stenman & C. Christofer Juhlin et al. · 2025

Links
TL;DR

Substantial subsets of non-ATCs express CD44v6, indicating that some patients may be candidates for [1⁷⁷Lu]Lu-DOTA-AKIR001 radiotherapy, particularly when conventional treatments are exhausted.

AI-generated by Semantic Scholar

Authors
Adam Stenman, Joachim N. Nilsson, Vincenzo Condello, Anja C. L. Mortensen, Marika Nestor, Jan Zedenius, C. Christofer Juhlin